Quick Answer
Aura Biosciences, Inc. reported Total Assets of $169.43 million for fiscal year 2025.
Aura Biosciences, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $169.43M | -7.2% |
| 2024 | $182.50M | -28.5% |
| 2023 | $255.07M | +13.9% |
| 2022 | $223.94M | +39.9% |
| 2021 | $160.03M | +624.0% |
| 2020 | $22.10M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $190.02M | -7.5% | -7.0% |
| June 30, 2025 | $204.40M | -6.4% | +31.5% |
| March 31, 2025 | $155.40M | -33.9% | -14.9% |
| December 31, 2024 | $182.50M | -28.5% | -11.1% |
| September 30, 2024 | $205.34M | +14.2% | -5.9% |
| June 30, 2024 | $218.28M | +13.3% | -7.1% |
| March 31, 2024 | $235.03M | +14.1% | -7.9% |
| December 31, 2023 | $255.07M | +13.9% | +41.9% |
- Aura Biosciences, Inc. showed a decrease of -7.2% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Aura Biosciences, Inc.’s total assets has grown by 666.5% (from $22.10 million to $169.43 million).
- The most recent figure is from Aura Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: